Clinical Trial Update: Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of vorinostat with carboplatin and gemcitabine in women with recurrent, platinum-sensitive ovarian cancer; study terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Vorinostat (vorinostat)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-10-04